tetano
Editor, Senior Moderator
J Eur Acad Dermatol Venereol
. 2021 Aug 7.
doi: 10.1111/jdv.17578. Online ahead of print.
Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature
E Annabi[SUP] 1 [/SUP], N Dupin[SUP] 1 2 3 [/SUP], P Sohier[SUP] 2 3 4 [/SUP], B Garel[SUP] 1 [/SUP], N Franck[SUP] 1 [/SUP], S Aractingi[SUP] 1 2 3 [/SUP], S Guégan[SUP] 1 2 3 [/SUP], B Oulès[SUP] 1 2 3 [/SUP]
Affiliations
Abstract
Among the vaccines against coronavirus disease 2019 (COVID-19), BNT162b2 from BioNtech-Pfizer and mRNA-1273 from Moderna are mRNA vaccines targeting the Spike protein of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The ChAdOx1 nCoV-19 (AZD1222) from Oxford-AstraZeneca is based on adenovirus expressing the full-length Spike protein. Clinical trials reported different cutaneous adverse events, mainly local injection site reactions, either immediate or delayed on/after 8 days.
Keywords: COVID-19 vaccines; cutaneous adverse effects.
. 2021 Aug 7.
doi: 10.1111/jdv.17578. Online ahead of print.
Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature
E Annabi[SUP] 1 [/SUP], N Dupin[SUP] 1 2 3 [/SUP], P Sohier[SUP] 2 3 4 [/SUP], B Garel[SUP] 1 [/SUP], N Franck[SUP] 1 [/SUP], S Aractingi[SUP] 1 2 3 [/SUP], S Guégan[SUP] 1 2 3 [/SUP], B Oulès[SUP] 1 2 3 [/SUP]
Affiliations
- PMID: 34363637
- DOI: 10.1111/jdv.17578
Abstract
Among the vaccines against coronavirus disease 2019 (COVID-19), BNT162b2 from BioNtech-Pfizer and mRNA-1273 from Moderna are mRNA vaccines targeting the Spike protein of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The ChAdOx1 nCoV-19 (AZD1222) from Oxford-AstraZeneca is based on adenovirus expressing the full-length Spike protein. Clinical trials reported different cutaneous adverse events, mainly local injection site reactions, either immediate or delayed on/after 8 days.
Keywords: COVID-19 vaccines; cutaneous adverse effects.